Fritextsökning
Innehållstyper
-
Major changes to the Q-Med board
The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.
-
Astra Zenecas Sverige-vd: ”Vi tror superstarkt på vår portfölj”
Det började med sommarjobb som operatör på Astras kemifabrik i Snäckviken. Över tre decennier och otaliga olika uppdrag senare är Södertäljesonen Per Alfredsson...
-
Welcome to wonderful Copenhagen
Strategically located, the Danish capital is the focal point of one of the most dynamic regions in Northern Europe. Here are some tips on where to spend your ti...
-
New study of toxins and heart disease
Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study...
-
Age essential when testing drugs
Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Crafoord Prize to an American and two Japanese
Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.
-
Go ahead for leg wound study
Tripep starts a phase II-study of their wound healing joint venture project.
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
Collaboration brings next generation drugs
Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.
-
A platform for dialogue
As a step towards connecting the life science industry in Denmark, Biologue was founded three years ago with 10 member companies. Today, the network has 40 memb...
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
-
Svensk-danskt event blir e-möte
I september anordnas Life Science Swedens två event The Future of Swedish & Danish Life Science och New Updates in Drug Formulation & Bioavailability för första...
-
Time to save for survival
The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
Årets opinionsartiklar
Missa inte de opinionsartiklar som har blivit mest lästa i Life Science Sweden.
-
Galderma bygger nytt
Planerar ny tillverkningsanläggning i Uppsala och visar upp lovande resultat från studie med ready to use-lösning av botulinumtoxin.
-
Apoteket gets new vice CEO
The Swedish government company Apoteket has recently appointed a vice CEO.
-
New map of eye proteins
A new mapping of proteins in the eye opens the door for new treatments of eye diseases in the future.
-
Fewer visitors but satisfied exhibitors
Biotech Forum Scanlab attracted fewer visitors than in 2008. Exhibition manager Bo Rasmussen is content, claiming that the exhibitors are very satisfied.
-
Ny kunskap om sällsynt grundämne
Forskare från Göteborgs universitet har lyckats skapa små mängder av världens mest sällsynta grundämne.
-
Anna Törner: Dags att ta av de rosa glasögonen
”Förhoppningsvis har vi snart situationen under kontroll i många europeiska länder, men ur ett globalt perspektiv så är försvinnande få människor vaccinerade. V...